Notatki do odcinka
The traditional biotech funding model hasn't fundamentally changed in decades: brilliant founders with promising science face an impossible choice; build expensive internal R&D capabilities or negotiate partnerships on terms controlled by Big Pharma. Tom Hopkins, VP and Head of Lilly ExploR&D, is working to flip that script. In this episode, Tom joins your host Mike Ward to discuss the four critical barriers early-stage biotechs face (expertise gaps, data infrastructure challeng...

